GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Nyxoah SA (STU:5YI) » Definitions » Future 3-5Y EPS without NRI Growth Rate

Nyxoah (STU:5YI) Future 3-5Y EPS without NRI Growth Rate : 14.82 (As of May. 14, 2025)


View and export this data going back to 2020. Start your Free Trial

What is Nyxoah Future 3-5Y EPS without NRI Growth Rate?

Future 3-5Y EPS without NRI Growth Rate is the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

As of today, Nyxoah's Future 3-5Y EPS without NRI Growth Rate is 14.82.


Competitive Comparison of Nyxoah's Future 3-5Y EPS without NRI Growth Rate

For the Medical Instruments & Supplies subindustry, Nyxoah's Future 3-5Y EPS without NRI Growth Rate, along with its competitors' market caps and Future 3-5Y EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nyxoah's Future 3-5Y EPS without NRI Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Nyxoah's Future 3-5Y EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Nyxoah's Future 3-5Y EPS without NRI Growth Rate falls into.


;
;

Nyxoah  (STU:5YI) Future 3-5Y EPS without NRI Growth Rate Explanation

Future 3-5Y EPS without NRI Growth Rate s the average growth rate of earnings per share (EPS) estimates over a 3-year to 5-year period.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average earnings per share (EPS) estimates growth rate.


Nyxoah Future 3-5Y EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Nyxoah's Future 3-5Y EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Nyxoah Business Description

Industry
Traded in Other Exchanges
Address
Rue Edouard Belin 12, Mont-Saint Guibert, BEL, 1435
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.

Nyxoah Headlines

No Headlines